Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q1 Loss of 55c/Share
Get Alerts AEGR Hot Sheet
Join SI Premium – FREE
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q1 EPS of ($0.55), $0.01 worse than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Aegerion Pharmaceuticals, Inc. (AEGR) click here.
For earnings history and earnings-related data on Aegerion Pharmaceuticals, Inc. (AEGR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- Bernstein SocGen Group Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share